Everolimus (RAD001) in Elderly Patients With Acute Myeloid Leukemia

Clinical trial NCT00636922 · UNKNOWN

Trial details

NCT number: NCT00636922
Sponsor: Bayside Health
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2010-02-01
Primary completion: 2013-07-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.